- NanoSphere Delivery System– a smart lipid nanoparticle delivery platform– is awarded the 2018 Technology Innovation Award by Frost & Sullivan as part of the annual Best Practices Awards for North America.
- Robert Sutton, CEO of Nanosphere Health Sciences: “The recognition of our NanoSphere Delivery System as a breakthrough innovation is a direct reflection of our team’s dedication to finding inventive solutions for improving the effectiveness and precision of how medical benefits are delivered,”
DENVER (May 23, 2018) – PRESS RELEASE – NanoSphere Health Sciences INC, the nano-biotechnology company that has commercialized a patented delivery system known as the NanoSphere Delivery System, has been awarded the 2018 Technology Innovation Award by Frost & Sullivan as part of the annual Best Practices Awards for North America. These awards recognize excellence across a number of fields and are the result of independent research conducted by Frost & Sullivan, which specializes in business growth partnerships.
The Technology Innovation category of 2018 was awarded based on criteria including technology attributes, future business value, application diversity, customer acquisition and beyond. Previous winners of the Best Practices Award category include key pharmaceutical players such as Nemaura Medical, Boehringer Ingelheim, 3M and Acino.
Independent research concluded that NanoSphere Health Sciences has achieved truly superior delivery of pharmaceutical, cosmetic and nutraceutical agents and that it outperforms competing solutions by providing significant biocompatibility, safety, efficacy and versatility. It was recognized that NanoSphere Health Sciences has effectively solved a complex problem in drug delivery with its unique ability to control the efficacy of drug formulations once inside the body.
The NanoSphere Delivery System is a smart lipid nanoparticle delivery platform….